Genital Warts Treatment, Brunei | HIV STD TESTING SINGAPORE™
Genital Warts Treatment, Brunei | HIV STD TESTING SINGAPORE™ @beautybrunei_com: Genital warts (condyloma, condylomata acuminata, venereal wart, anal wart, anogenital wart, "cauliflower" sex disease) symptoms in men/women, screening/diagnosis, testing/check, treatment clinic, Brunei - Private and confidential service. Definitions, references, and latest news.
Keywords: Genital Warts Treatment Brunei, Brunei Genital Warts Treatment, Genital Warts Treatment.
| Advertisement: Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic: |
| SHIM CLINIC|
168 Bedok South Avenue 3 #01-473
Tel: (+65) 6446 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Web: Genital Warts Treatment, Brunei
| Opening Hours |
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: one hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.
Sexual risk (of HIV/STD/pregnancy), and what you can do before and after exposure.
Many throat cancer patients can skip neck surgery
Wed, 17 Sep 2014 16:07:03 +0100 | ScienceDaily Headlines
Patients with human papillomavirus (HPV) -- the same virus associated with both cervical and head and neck cancer -- positive oropharyngeal cancer see significantly higher rates of complete response on a post-radiation neck dissection than those with HPV-negative oropharyngeal cancer, researchers report. (Source: ScienceDaily Headlines)
HPV urine test could screen for cervical cancer
Wed, 17 Sep 2014 11:00:00 +0100 | NHS News Feed
Many throat cancer patients can skip neck surgery
Wed, 17 Sep 2014 04:00:00 +0100 | EurekAlert! - Cancer
(Fox Chase Cancer Center) A new study shows that patients with human papillomavirus (HPV) -- the same virus associated with both cervical and head and neck cancer -- positive oropharyngeal cancer see significantly higher rates of complete response on a post-radiation neck dissection than those with HPV-negative oropharyngeal cancer. Fox Chase Cancer Center researchers presented the findings at the American Society for Radiation Oncology's 56th Annual Meeting on Wednesday, Sept. 17. (Source: EurekAlert! - Cancer)
Urine HPV Testing an Acceptable Alternative to Cervical HPV Testing? (FREE)
Wed, 17 Sep 2014 00:00:00 +0100 | Physician's First Watch current issue
By Amy Orciari Herman
Natural killer and dendritic cells collaborate in the immune response induced by the vaccine against uterine cervical cancer
Wed, 17 Sep 2014 00:00:00 +0100 | European Journal of Immunology
This article is protected by copyright. All rights reserved (Source: European Journal of Immunology)
Improved HPV vaccine uptake could prevent 200 cervical cancer cases every year
Tue, 16 Sep 2014 08:43:07 +0100 | Pharmacy Europe
Around 200 cases of cervical cancer and 90 deaths from the disease could be prevented each year if uptake of the HPV (human papillomavirus) vaccine was increased in every region to just ten per cent more than the current national average, according to research1 presented at the Public Health England conference in Warwick. (Source: Pharmacy Europe)
Expression profile and in vitro blockade of programmed death‐1 in human papillomavirus–negative head and neck squamous cell carcinoma
Tue, 16 Sep 2014 00:00:00 +0100 | Head and Neck
ConclusionOur data strongly supports the use of αPD‐1 blockade in patients with HPV‐negative HNSCC that are refractory to standard treatments. © 2014 Wiley Periodicals, Inc. Head Neck, 2014 (Source: Head and Neck)
TP53 and PIK3CA gene mutations in adenocarcinoma, squamous cell carcinoma and high-grade intraepithelial neoplasia of the cervix
Tue, 16 Sep 2014 00:00:00 +0100 | Journal of Translational Medicine
Anal intraepithelial neoplasia: a single centre 19 year review
Tue, 16 Sep 2014 00:00:00 +0100 | Colorectal Disease
ConclusionThe findings support the slow progression of AIN as described in the literature. In our small series, a two‐tiered system with further subclassification of the traditional AIN II group using p16 appears to be clinically useful. (Source: Colorectal Disease)
The difference in sensitivity between HPV testing and cytology for detecting current and future CIN2+ increases over time
Mon, 15 Sep 2014 00:00:00 +0100 | Evidence-Based Medicine
Commentary on: Elfström KM, Smelov V, Johansson AL, et al.. Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial. BMJ 2014;348:g130. Context Human papillomavirus (HPV) testing is more sensitive but less specific than cytology for detecting CIN2+.1 Longitudinally, the cumulative rate of CIN2+ 6 years after a negative HPV test is similar to the rate 3 years after negative cytology.2 However, some researchers have suggested that this improved sensitivity is due to overdiagnosis of regressive lesions.3 Meta-analysis of randomised controlled trials shows that screening with HPV testing prevents more cervical cancers than with cytology.4 There is little evidence regarding CIN2+ more than 6 years after H...